← Back to Clinical Trials
Recruiting NCT07338292

NCT07338292 VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07338292
Status Recruiting
Phase
Sponsor Istituto Oncologico Veneto IRCCS
Condition Urologic Diseases
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-12-17
Primary Completion 2026-09-30

Trial Parameters

Condition Urologic Diseases
Sponsor Istituto Oncologico Veneto IRCCS
Study Type INTERVENTIONAL
Phase N/A
Enrollment 56
Sex ALL
Min Age 18 Years
Max Age 99 Years
Start Date 2025-12-17
Completion 2026-09-30
Interventions
REALICAClinical Practice

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Though the efficacy of VRH is documented in various outpatient urological procedures and has provided promising preliminary information in prostate biopsy, its systematic use in urology remains poorly studied. Considering the potential of invasive urological procedures to induce significant patient discomfort, the application of innovative immersive approaches, such as those offered by medical devices, could lead to an overall clinical benefit. Among these, REALICA® (available from https://REALICA.io/en/), a class I CE medical device, widely used in hospitals and validated by numerous studies, represents a valuable resource in urology, supported by high satisfaction rates received in abdominal surgery and extracorporeal lithotripsy

Eligibility Criteria

Inclusion Criteria: * Male/female with age ≥ 18 years * Patient who are undergoing one of the interventions mentioned in the study for the first time; * Eligibility for minimally invasive ambulatory urological procedures, possibly requiring vascular access (circumcision, prostate biopsy, flexible cystoscopy); * Ability to understand instructions and complete study questionnaires; * Signed informed consent. Exclusion Criteria: * Absolute contraindications to the planned urological procedure (e.g., active urinary tract infection, anatomical urethral abnormalities); * Recent urological manipulations (e.g., urethral dilation, bladder biopsy, insertion or removal of a double-J stent); * Medical contraindications to the use of virtual reality, including uncontrolled photosensitive epilepsy and relevant neurological, ophthalmologic, or otolaryngologic disorders; * Presence of severe psychiatric disorders or major cardiovascular diseases that may interfere with study participation; * Previous

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology